BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3572144)

  • 1. [Comparison of classic actuarial method with maximum likelihood methods for estimation of cumulative survival rate].
    Maetani S; Tobe T; Hirakawa A
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2421-9. PubMed ID: 3572144
    [No Abstract]   [Full Text] [Related]  

  • 2. [Estimation of survival rates: technics used (author's transl)].
    Rodary C; Laplanche A; Comnougue C; Flamant R
    Bull Cancer; 1979; 66(5):575-80. PubMed ID: 554686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methodology for the study of prognostic factors in oncology. I. Actuarial analysis].
    Sánchez Durán A
    Med Clin (Barc); 1988 Jan; 90(4):166-9. PubMed ID: 3352352
    [No Abstract]   [Full Text] [Related]  

  • 4. [A statistical study on the survival rate].
    Fukuhisa K; Takeda E
    Gan No Rinsho; 1985 Sep; 31(12):1621-31. PubMed ID: 4079052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An actuarial method used to analyse the results of tubal surgery for sterility (author's transl)].
    Querleu D
    J Gynecol Obstet Biol Reprod (Paris); 1981; 10(6):527-34. PubMed ID: 7320447
    [No Abstract]   [Full Text] [Related]  

  • 6. [Actuarial survival].
    Jacquillat CL; Hucher M
    Nouv Presse Med; 1981 Apr; 10(18):1459-60. PubMed ID: 7255117
    [No Abstract]   [Full Text] [Related]  

  • 7. A time series modeling approach in risk appraisal of violent and sexual recidivism.
    Bani-Yaghoub M; Fedoroff JP; Curry S; Amundsen DE
    Law Hum Behav; 2010 Oct; 34(5):349-66. PubMed ID: 19399599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 'quick hit' method to assess insurance mortality from a clinical article.
    Iacovino JR
    J Insur Med; 1994; 26(3):317-8. PubMed ID: 10150506
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer registry data: actuarial survival estimation in lung cancer patients.
    Vích Z
    Neoplasma; 1988; 35(2):129-33. PubMed ID: 3374703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity, mortality, and the C-2 risk.
    Cowell M
    J Insur Med; 1994; 26(3):313-6. PubMed ID: 10150505
    [No Abstract]   [Full Text] [Related]  

  • 11. Statistical analysis of survival data.
    Crowley J; Breslow N
    Annu Rev Public Health; 1984; 5():385-411. PubMed ID: 6372816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer registration: principles and methods. Analysis of survival.
    Parkin DM; Hakulinen T
    IARC Sci Publ; 1991; (95):159-76. PubMed ID: 1894319
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic factors in cancer of the testis: an approach to identification.
    Goldman A; Bosl G; Johnson K; Fraley EE; Kennedy BJ
    Cancer Treat Rep; 1980; 64(2-3):487-96. PubMed ID: 7407788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actual and actuarial probabilities of competing risks: apples and lemons.
    Grunkemeier GL; Jin R; Eijkemans MJ; Takkenberg JJ
    Ann Thorac Surg; 2007 May; 83(5):1586-92. PubMed ID: 17462363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using actuarial models to assess managed care risk.
    Pyenson BS
    Healthc Financ Manage; 1997 Jan; 51(1):35-6, 38. PubMed ID: 10163889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-parametric analysis of the survival of cancer patients. Review of methods].
    Kadyrova NO; Iakovlev AIu
    Vopr Onkol; 1984; 30(8):35-48. PubMed ID: 6385477
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing the likelihood of an important clinical outcome: new insights from a comparison of clinical and actuarial judgment.
    Rakow T; Vincent C; Bull K; Harvey N
    Med Decis Making; 2005; 25(3):262-82. PubMed ID: 15951454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment ... now!
    Bentzen SM; Vaeth M; Pedersen DE; Overgaard J
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1531-4. PubMed ID: 7635798
    [No Abstract]   [Full Text] [Related]  

  • 19. On competitive failure modes and the usefulness of a "survival curve point of view".
    Wolbarst AB
    Med Phys; 1983; 10(2):232-6. PubMed ID: 6865863
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival after pathological stage IA nonsmall cell lung cancer: tumor size matters.
    Birim O; Kappetein AP; Takkenberg JJ; van Klaveren RJ; Bogers AJ
    Ann Thorac Surg; 2005 Apr; 79(4):1137-41. PubMed ID: 15797040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.